📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
-
- Net Income Growth Range (1Y):
-
- Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 SGX Earnings Announcements for GRU
CGS Fullgoal CSI 1000 ETF (GRU)
Market: SGX |
Currency: USD
Address:
📈 CGS Fullgoal CSI 1000 ETF Historical Chart
🧾 Recent Financial Statement Analysis
November 19, 2025
Vallianz Holdings Enters Joint Venture for Marine Electrification Vallianz Holdings Announces Strategic Joint Venture in Marine Electrification Market Singapore, 18 November 2025 – Vallianz Holdings Limited (“Vallianz”), a leading offshore marine and engineering solutions provider, has announced a significant joint…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: GRU, CGS Fullgoal CSI 1000 ETF
November 19, 2025
Vallianz Holdings Enters Joint Venture for Marine Electrification Vallianz Holdings Announces Strategic Joint Venture in Marine Electrification Market Singapore, 18 November 2025 – Vallianz Holdings Limited (“Vallianz”), a leading offshore marine and engineering solutions provider, has announced a significant joint…
May 18, 2025
IPO Details Purpose of IPO: Hengrui Pharma aims to raise up to HK$9.89 billion (US$1.27 billion) through its Hong Kong listing. The proceeds are allocated as follows: Approximately 45% for funding clinical studies of innovative drugs and candidates. Around 20%…
